Showing results (1231-1240 of 14,091) with videos related to
Sort By:
Pageof 1,410
Gynecologic Oncology|October 7, 2008
Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancerThomas J Herzog, Matthew A Powell, Janet S Rader, et al.Gynecologic Oncology|October 7, 2008
Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancerSean C Dowdy, Giovanni Aletti, William A Cliby, et al.Gynecologic Oncology|December 9, 2008
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II studyAkin Atmaca, Salah-Eddin Al-Batran, Antje Neumann, et al.Gynecologic Oncology|December 9, 2008
Cervical cancer survivorship in a population based sampleKimlin T Ashing-Giwa, Judith S Tejero, Jinsook Kim, et al.Gynecologic Oncology|February 27, 2009
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancerNinke Leffers, Marloes J M Gooden, Anna A Mokhova, et al.Gynecologic Oncology|February 27, 2009
Microlaparoscopy: a further development of minimally invasive surgery for endometrial cancer staging -- initial experienceFabio Ghezzi, Antonella Cromi, Gabriele Siesto, et al.Gynecologic Oncology|December 17, 2008
Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South AfricaArthi Vijayaraghavan, Molly Efrusy, Gerhard Lindeque, et al.Gynecologic Oncology|January 30, 2009
Is centralization of ovarian cancer care warranted? A cost-effectiveness analysisJacoba P Greving, Flora Vernooij, A Peter M Heintz, et al.Gynecologic Oncology|January 31, 2009
A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancerTrond M Michelsen, Anne Dørum, Alv A DahlGynecologic Oncology|January 17, 2009
The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cellsKaren McLean, Natalie A VanDeVen, Dorothy R Sorenson, et al.Pageof 1,410